Effect of Wuling caspule on adolescent with mild to moderate anxiety and depression state

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040520

Enrollment

Unknown

Registered

2020-12-01

Start date

2020-12-31

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate anxiety and depression

Interventions

Exposed group:psychotherapy+Wuling capsule

Non-exposed group:psychotherapy

Eligibility

Sex/Gender

All

Age

8 Years to 17 Years

Inclusion criteria

Inclusion criteria: (1) aged 8 to 17 years old; (2) Meet the DSM - 5 diagnostic criteria; (3) Hamilton rating scale (HAMD - 17) > 17 or Hamilton scale (HAMA - 14) > 14 (4) Implement the psychological intervention treatment (5)The subjects and their guardians willing to sign a consent form to participate in this study

Exclusion criteria

Exclusion criteria: (1) the Hamilton rating scale (HAMD - 17) > 24 or the Hamilton scale (HAMA - 14) > 29; (2) Have obvious suicide; (3) Mental retardation, history of neuropsychiatric disorders such as schizophrenia, epilepsy; (4) Head trauma history (losing consciousness more than 10 minutes), the instability of other major body disease or mental symptoms caused by the body; (5) Suspected mental retardation; (6) has a history of alcohol or substance abuse.

Design outcomes

Primary

Measure	Time frame
Hamilton Depression Scale-17 items;Hamilton Anxiety Scale -14;	—

Secondary

Measure	Time frame
Self-rating Scale for Depression in Children ;Screening Scale for Anxiety disorders in children;Pittsberg Sleep Quality Index,;	—

Countries

China

Contacts

Public ContactLuo Hong

The Affiliated Hospital of Hangzhou Normal University

luohong@hzun.edu.cn+86 15958018854

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026